Different roles for plasminogen activators and metalloproteinases in melanoma metastasis

Current Topics in Microbiology and Immunology

Volumn 213 I, Issue , 1996, Pages 65-80

  Mueller, B M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; PLASMINOGEN ACTIVATOR;

EXTRACELLULAR MATRIX; HUMAN; MELANOMA; METASTASIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0029882374     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-61107-0_5     Document Type: Review

References (79)

1. Adams JC, Watt FM (1993) Regulation of development and differentiation by the extracellular matrix. Development 117. 1183-1198
2. Anderson RGW (1993) Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90 10909-10913
3. Aoyama A, Chen WT (1990) A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells Proc Natl Acad Sci USA 87 8296-8300
4. Axelrod JH, Reich R, Miskin R (1989) Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Mol Cell Biol 9: 2133-2141
5. Bizik J, Stephens RW, Grofova M, Vaheri A (1993) Binding of tissue-type plasminogen activator to human melanoma cells. J Cell Biochem 51. 326-335
6. Blasi F (1993) Urokinase and urokinase receptor. a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15. 105-111
7. Boike G, Lan T, Sloane BF, Rozhin J, Honn K, Guirguis R, Stracke ML, Liotta LA, Schiffman E (1991) A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumor cells. Melanoma Res 1. 333-340
8. Chirivi RGS, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, Giavazzi R (1994) Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor Int J Cancer 58: 460-464
9. Clark WH (1991) Tumour progression and the nature of cancer. Br J Cancer 64: 631-644
10. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD (1993) Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90: 5021-5025
11. Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activation, tissue degradation and cancer. Adv Cancer Res 44: 139-266
12. DeClerck YA, Imren S (1994) Protease inhibitors role and potential therapeutic use in human cancer. Eur J Cancer 30A 2170-2180
13. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701-708
14. Delbaldo C, Massouye I, Saurat J-H, Vassaili J-D, Sappino A-P (1994) Plasminogen activation in melanocytic neoplasia. Cancer Res 54: 4547-4552
15. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM (1993) Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions Pharmacol Ther 59: 329-341
16. De Vries TJ, Quax PHA, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, Van Muijen GNP (1994) Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144: 70-81
17. Ellis V, Pyke C, Eriksen J, Solberg H, Danø K (1992) The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sci 667: 13-31
18. Frisch SM, Werb Z (1989) Molecular biology of collagen degradation. In Olsen BR, Nimni ME (eds) Collagen: molecular biology, vol IV. CRC Press, Boca Raton, Florida, pp 85-105
19. Hajjar KA, Jacovina AT, Chacko J (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269: 21191-21197
20. Hearing VJ, Law JW, Corti A, Appella E, Blasi F (1988) Modulation of metastastic potential by cell surface urokinase of murine melanoma cells. Cancer Res 48: 1270-1278
21. Hendrix MJC, Wood WR, Seftor EA, Lotan D, Nakajima D, Misiorowski RL, Seftor REB, Stetler-Stevenson WG, Bevacqua SJ, Liotta LA, Sobel ME, Raz A, Lotan A (1990) Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factors. Cancer Res 50: 4121-4130
22. Herlyn M (1993) Molecular and cellular biology of melanoma Landes Austin, Texas
23. Hoal-Van Helden EG, Wilson EL, Dowdle EB (1986) Characterization of seven human melanoma cell lines melanogenesis and secretion of plasminogen activators. Br J Cancer 54: 287-295
24. Johnson MD, Kim HR, Chesler L, Tsao WG, Bouck N, Polverini PJ (1994) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160: 194-202
25. Khokha R (1994) Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86: 299-304
26. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P (1992a) Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 84: 1017-1022
27. Khokha R, Zimmer MJ, Wilson SM, Chambers A (1992b) Up-regulation of TIMP-1 expression in B16-F10 melanoma cells supresses their metastatic ability in chick embryo. Clin Exp Metastasis 10: 365-304
28. Kirchheimer JC, Wojta J, Christ G, Binder BR (1989) Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. Proc Natl Acad Sci USA 86: 5424-5428
29. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC (1994) Overexpression of metalloproteinase inhibitor in B16-F10 cells does not affect extravasation but reduces tumor growth Cancer Res 54: 4791-4797
30. Kwaan HC (1992) The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11: 291-311
31. Laug WE, Cao XR, Yu YB, Shimada H, Kruithof EKO (1993) Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2. Cancer Res 53: 6051-6057
32. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation Cell 64: 327-336
33. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M (1994) Caveolae, caveolin and caveolain-rich membrane domains: a signalling hypothesis Trends Cell Biol 4: 231-235
34. MacDougall JR, Bani MR, Lin Y, Rak J, Kerbel RS (1995) The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55: 4174-4181
35. Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP (1990) Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases Cancer Res 50: 5997-6001
36. Matrisian LM (1992) The matrix-degrading metalloproteinasess Bioessays 14: 455-463
37. Mareel MM, De Baetselier P, Van Roy FM (1991) Cellular activities implicated in invasion and metastasis In: Mareel MM, De Baetselier P, Van Roy FM (eds) Mechanisms of invasion and metastasis CRC Press, Boca Raton, Florida, pp 73-219
38. McDonald J (1988) Extracellular matrix assembly. Annu Rev Cell Biol 4: 183-207
39. Meissauer A, Kramer MD, Hofmann M, Erkell LJ, Jacob E, Schirrmacher V, Brunner G (1991) Urokinase-type and tissue type plasminogen activators are essential for in vitro invasion of human melanoma cells Exp Cell Res 192: 453-459
40. Meissauer A, Kramer MD, Schirrmacher V, Brunner G (1992) Generation of cell surface-bound plasmin by cell associated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma invasiveness in vitro Exp Cell Res 199: 179-190
41. Menrad A, Speicher D, Wacker J, Herlyn M (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells Cancer Res 53. 1450-1455
42. Mignatti P, Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73 161-195
43. Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487-498
44. Miles LA, Dahlberg CM, Plescia J, Felez, Kato K, Plow EF (1991) Role of cell surface lysines in plasminogen binding to cells: identification of α-enolase as a candidate plasminogen receptor. Biochemistry 30: 1682-1686
45. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, Chen WT (1994) A potential marker of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 54. 5702-5710
46. Montgomery AMP, De Clerck YA, Langley KE, Reisfeld RA, Mueller BM (1993) Melanoma-mediated dissolution of extracellular matrix. Contribution of urokinase-dependent and metalloproteinase dependent proteolytic pathways. Cancer Res 53: 693-700
47. Montgomery AMP, Mueller BM, Reisfeld RA, Taylor SM, De Clerck YA (1994a) Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467-5473
48. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen Proc Natl Acad Sci USA 91. 8856-8860
49. Moses MA, Langer R (1991) A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 47. 230-235
50. Mueller BM, Romerdahl CA, Trent JM, Reisfeld RA (1991) Suppression of spontaneous melanoma metastasis in SCID mice with an antibody to the epidermal growth factor receptor. Cancer Res 51: 2193-2198
51. Mueller BM, Yu YB, Laug WE (1995) Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc Natl Acad Sci USA 92. 205-209
52. Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J, Reynolds JJ (1994) Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 732. 31-41
53. Nakajima M, Irimura T, Nicolson GL (1988) Heparanases and tumor metastasis. J Cell Biochem 36: 157-167
54. Ossowski L (1992) Invasion of connective tissue by human carcinoma cell lines. requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res 52: 6754-6760
55. Ossowki L, Reich E (1983) Antibodies to plasminogen activator inhibit human tumor metastasis Cell 35. 611-619
56. Ossowski L Russo-Payne H, Wilson EL (1991) Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res 51: 274-281
57. Paufi BU, Arsenis C, Hohberger LH, Schwart DE (1986) Connective tissue degradation by invasive rat bladder carcinomas, action of nonspecific proteinases on collagenous matrices Cancer Res 46: 2005-2012
58. Quax PHA, Van Muijen GNP, Weening-Verhoeff EJD, Lund LR, Danø K, Ruiter DJ, Verheijen JH (1991) Metastatic behaviour of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation J Cell Biol 115: 191-199
59. Ray JA, Stetter-Stevenson WG (1994) TIMP-2 expression modulates human melanoma cell adhesion and motility. Ann NY Acad Sci 732: 233-247
60. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastastic cells. Cancer Res 48: 3307-3312
61. Rijken DC, Collen D (1981) Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Bioi Chem 256: 7035-7041
62. Rozhin J, Wade R, Honn KV, Sloane BF (1989) Membrane associated cathepsin L: a role in metastasis of melanomas Biochem Biophys Res Commun 164: 556-561
63. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells Nature 370: 61-65
64. 3 integrin in human melanoma invasion. Proc Natl Acad Sci USA 89: 1557-1561
65. 5β, integrins during human melanoma cell invasion Cancer Res 53: 3411-3415
66. Sloane BF, Moin K, Krepela E, Rozhin J (1990) Cathepsin B and its endogenous inhibitors: The role in tumor malignancy Cancer Metastasis Rev 9: 333-352
67. Stahl A, Mueller BM (1994) Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54: 3066-3071
68. Stahl A, Mueller BM (1995) The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae J Cell Biol 129: 335-344
69. Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu Rev Cell Biol 9. 541-573
70. Testa JE, Quigley JP (1990) The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastais Rev 9: 35-367
71. Tsushima H, Hyodoh F, Yoshida E, Ueki A, Hopsu-Havu VK (1991a) Inacative cathepsin B-like enzyme in human melanoma culture medium. Melanoma Res 1 341-347
72. Tsushima H, Ueki A, Matsuoka Y, Mihara H, Hopsu-Havu VK (1991b) Characterization of a cathepsin-H-like enzyme from a human melanoma cell line. Int J Cancer 48. 726-732
73. 2-Macroglobulin in the regulation of pericellular plasminogen activation of human tumor cells. Ann NY Acad Sci 737 409-418
74. Vassalli J-D, Sappino A-P, Belin D (1991) The plasminogen activator/plasmin system. J Clin Invest 88: 1067-1072
75. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM (1994) Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice Cancer Res 54: 4726-4728
76. Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, Yohem KH, Gilmore LB, Seftor REB, Nakajima M, Hendrix MJC (1991) Characterization of a highly invasive and spontaneously metastastic human malignant melanoma cell line. Int J Cancer 47: 227-237
77. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, Matrisian LM (1994) Modulation of matrilysin levels in colon carcinoma cell affects tumorigenicity in vivo. Cancer Res 54. 4805-4812
78. Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5. 2145-2154
79. Yu, H, Schultz RM (1990) Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes Cancer Res 50: 7623-7633